Show items per page
Elements: 8
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV Rutschmann, Olivier Thierry; Negro, Francesco; Hirschel, Bernard; Hadengue, Antoine; ... Perrin, L. H. 1998
add to browser selection
Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study Krischer, Joachim; Rutschmann, Olivier Thierry; Hirschel, Bernard; Vollenweider-Roten, S.; ... Pechere, Marc 1998
add to browser selection
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study Lorenzi, P.; Opravil, M.; Hirschel, Bernard; Chave, J. P.; ... Yerly Ferrillo, Sabine 1999
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Substitution for protease inhibitors in HIV therapy Hirschel, Bernard 2003
add to browser selection
Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir Ananworanich, Jintanat; Hirschel, Bernard; Sirivichayakul, Sunee; Ubolyam, Sasiwimol; ... Ruxrungtham, Kiat 2006
add to browser selection
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types von Wyl, Viktor; Yerly Ferrillo, Sabine; Boni, Jurg; Burgisser, Philippe; ... Gunthard, Huldrych 2007
add to browser selection
No patient left behind--better treatments for resistant HIV infection Hirschel, Bernard; Perneger, Thomas 2007